GI
ALLO icon

GAMMA Investing’s Allogene Therapeutics ALLO Stock Holding History

GAMMA Investing’s Portfolio ALLO Stock Details ALLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$25.9K Buy
16,219
+894
+6% +$1.7K ﹤0.01% 2779
2026
Q2 		$31.9K Buy
15,325
+194
+1% +$426 ﹤0.01% 2575
2026
Q1 		$36.9K Buy
15,131
+2,079
+16% +$4.17K ﹤0.01% 2381
2025
Q4 		$17.9K Buy
+13,052
New +$17.2K ﹤0.01% 2672

Other funds holding ALLO

TC
Trust Company Manhattan, Kansas $1.15B AUM 7.83% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing's ALLO Position: Q3 2026 in Review

GAMMA Investing increased its Allogene Therapeutics (ALLO) stake by 5.8% in Q3 2026, buying an estimated $1.7K and bringing the position to 16,219 shares worth $25.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2779.

GAMMA Investing first reported a position in ALLO in Q4 2025 and has held it in 4 quarters since. The position peaked at $36.9K in Q1 2026. 3 funds tracked by Wall St. Rank hold ALLO as of Q3 2026.

  • GAMMA Investing held 16,219 shares of Allogene Therapeutics worth $25.9K as of Q3 2026.
  • GAMMA Investing bought 894 Allogene Therapeutics shares in Q3 2026, an estimated $1.7K.
  • Allogene Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2779 holding.
  • GAMMA Investing first reported a position in Allogene Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • GAMMA Investing's Allogene Therapeutics position peaked at $36.9K in Q1 2026.
  • 3 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.